Loading investment pitches...
Equity Research Database
Institutional Investment Pitches
Explore thousands of hedge fund pitches, high-conviction equity research memos, and portfolio manager commentary extracted from quarterly letters.
Explore thousands of hedge fund pitches, high-conviction equity research memos, and portfolio manager commentary extracted from quarterly letters.
Underperformed due to weaker-than-expected service bookings which lowered guidance. However, the appointment...
— Chad Meade
Full equity research memos, financial breakdowns, and hedge fund thesis write-ups are reserved for BSD Research ($50/mo) and Pro subscribers.
Already a Research or Pro subscriber? Sign In
Other investors who've written on Certara, Inc.
No other institutional pitches found for this ticker yet.
More institutional theses from Meridian Small Cap Growth Fund
Hinge Health's stock advanced following an earnings beat, an upward revision to full-year guidance, and accelerating client bookings. The company also...
Definium's stock more than doubled following strong Phase 3 results for its LSD-based major depressive disorder therapy, which exhibited durable treatment effects and high remission rates. This clinical milestone...
Tandem Diabetes Care is an automated insulin delivery technology provider poised for long-term growth in both Type 1 and Type 2 diabetes markets. Although near-term U.S....